The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis.

BMC Cancer · 2022 · PMC9628061 · PMID 36319973

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Lastly, in patients with T4 or N2 disease, this study showed a trend for improved survival in those patients with an oxaliplatin DI of > 80% compared to those with an oxaliplatin DI of ≤ 80%.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.